Vocxi Health
Vocxi Health is a pioneering medical device company dedicated to early disease detection through innovative breath analysis technology. Their flagship product, MyBreathPrint®, is a noninvasive, rapid, and accurate system that detects diseases such as lung cancer by analyzing volatile organic compounds in a patient's breath. The company's mission is to create the most accessible and precise breath sensor to understand patient health early, transforming the patient journey and improving health outcomes worldwide.
Industries
Nr. of Employees
small (1-50)
Vocxi Health
Hills, Minnesota, United States, North America
Products
Portable breath analyzer with nanosensor array
A small, handheld breath collection device that captures one minute of exhaled breath via a mask and measures VOC-induced electrochemical signals using a nanosensor array for diagnostic analysis.
Cloud-based breath pattern analysis platform
A cloud-hosted analytics platform that receives sensor electrochemical patterns, applies machine learning to generate a diagnostic BreathPrint, and returns results to clinicians.
MyBreathPrint
MyBreathPrint is a handheld breath analysis device that uses a cross functional array of nanosensors based on graphene and functionalized chemical monolayers to detect volatile organic compounds (VOCs) in breath, creating unique BreathPrints for disease detection without reagents or lab work.
MyBreathPrint® (MBP-001)
The MyBreathPrint® system is a handheld breath analyzer paired with a mobile phone application and web portal, designed to analyze exhaled breath for assessing the risk of malignancy in patients with pulmonary nodules.
Vocxi Health Point-of-Care Breath Test for Lung Cancer
A point-of-care breath test for lung cancer that uses highly sensitive biosensors and machine learning to detect volatile organic compounds in breath.
Vocxi Health breath analysis device
A device that detects disease by sensing chemicals in a person's breath, targeting patients suspected of having lung cancer.
Portable breath analyzer with nanosensor array
A small, handheld breath collection device that captures one minute of exhaled breath via a mask and measures VOC-induced electrochemical signals using a nanosensor array for diagnostic analysis.
Cloud-based breath pattern analysis platform
A cloud-hosted analytics platform that receives sensor electrochemical patterns, applies machine learning to generate a diagnostic BreathPrint, and returns results to clinicians.
MyBreathPrint
MyBreathPrint is a handheld breath analysis device that uses a cross functional array of nanosensors based on graphene and functionalized chemical monolayers to detect volatile organic compounds (VOCs) in breath, creating unique BreathPrints for disease detection without reagents or lab work.
MyBreathPrint® (MBP-001)
The MyBreathPrint® system is a handheld breath analyzer paired with a mobile phone application and web portal, designed to analyze exhaled breath for assessing the risk of malignancy in patients with pulmonary nodules.
Vocxi Health Point-of-Care Breath Test for Lung Cancer
A point-of-care breath test for lung cancer that uses highly sensitive biosensors and machine learning to detect volatile organic compounds in breath.
Vocxi Health breath analysis device
A device that detects disease by sensing chemicals in a person's breath, targeting patients suspected of having lung cancer.
Services
Collaborative deployment of breath-based screening workflows with healthcare providers to support early detection, triage, and monitoring.
Design and execution of IRB-approved human clinical studies to validate diagnostic performance of breath-sensor systems.
Integration of device data with mobile applications and cloud analytics platforms, enabling automated analysis and clinician notification.
Collaborative deployment of breath-based screening workflows with healthcare providers to support early detection, triage, and monitoring.
Design and execution of IRB-approved human clinical studies to validate diagnostic performance of breath-sensor systems.
Integration of device data with mobile applications and cloud analytics platforms, enabling automated analysis and clinician notification.
Expertise Areas
- Breath-based diagnostics and metabolomics
- Nanosensor materials and surface chemistry
- Wafer-scale sensor manufacturing
- Machine learning for chemical pattern recognition
Key Technologies
- Graphene-based nanosensors
- Self-assembled monolayer receptor chemistry
- Electrochemical sensor arrays
- Volatile organic compound (VOC) analysis
News & Updates
Vocxi Health was selected as a finalist in the HealthTech, MedTech, BioTech & Accessibility category for the 17th annual SXSW Pitch.
Vocxi Health was selected out of 400+ companies to present their poster at the 2024 BLUE KNIGHT™ Symposium, an initiative between Johnson & Johnson and BARDA.
Vocxi won the best pitch in the Healthcare/Tech Track at Venture Summit West, competing against dozens of global health tech companies.
Selected as a finalist in the SXSW Pitch for innovative early disease detection technology.
Selected to present at the BLUE KNIGHT™ Symposium, a joint initiative between Johnson & Johnson and BARDA.
Won best pitch in the Healthcare/Tech Track at Venture Summit West.
Vocxi Health was selected as a finalist in the HealthTech, MedTech, BioTech & Accessibility category for the 17th annual SXSW Pitch.
Vocxi Health was selected out of 400+ companies to present their poster at the 2024 BLUE KNIGHT™ Symposium, an initiative between Johnson & Johnson and BARDA.
Vocxi won the best pitch in the Healthcare/Tech Track at Venture Summit West, competing against dozens of global health tech companies.
Selected as a finalist in the SXSW Pitch for innovative early disease detection technology.
Selected to present at the BLUE KNIGHT™ Symposium, a joint initiative between Johnson & Johnson and BARDA.
Won best pitch in the Healthcare/Tech Track at Venture Summit West.